Physician profile
Tanner Olsen
NPI 1942840335
$2,528.69
in general payments reported to CMS, 2019-2025
10 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $595 · 2022: $645 · 2023: $995 · 2024: $117 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,159.04 | 2021-2024 | Proclaim |
| Relievant Medsystems, INC. | $284.97 | 2023 | Intracept |
| Boston Scientific Corporation | $283.24 | 2022-2025 | Intracept Rf Probe |
| Collegium Pharmaceutical, INC. | $252.69 | 2021-2023 | Xtampza |
| Medtronic, INC. | $198.03 | 2021-2023 | Intellis Adaptivestim |
| Nevro Corp. | $143.20 | 2022 | |
| Nalu Medical, INC. | $137.19 | 2023 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.29 | 2025 | Relistor |
| Smith+Nephew, INC. | $19.41 | 2021 | |
| Biodelivery Sciences International, INC. | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Olsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.